Sign Up to like & get
recommendations!
1
Published in 2022 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2022.5610
Abstract: Key Points Question Can tucatinib, trastuzumab, and capecitabine provide systemic and intracranial benefit for patients with ERBB2 (HER2)-positive metastatic breast cancer and brain metastases? Findings In this exploratory subgroup analysis of a randomized clinical trial…
read more here.
Keywords:
trastuzumab capecitabine;
breast cancer;
brain metastases;
brain ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "European journal of cancer"
DOI: 10.1016/j.ejca.2021.05.025
Abstract: AIMS In HER2CLIMB, tucatinib significantly improved progression-free and overall survival in patients with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer. We evaluated the impact of tucatinib on health-related quality of life (HR-QoL)…
read more here.
Keywords:
trastuzumab capecitabine;
tucatinib placebo;
breast cancer;
metastatic breast ... See more keywords